Indaptus Therapeutics, Inc.
General ticker "INDP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.1M (TTM average)
Indaptus Therapeutics, Inc. follows the US Stock Market performance with the rate: 12.9%.
Estimated limits based on current volatility of 5.3%: low 3.10$, high 3.45$
Factors to consider:
- Earnings expected soon, date: 2026-11-17 bmo
- Total employees count: 5 (-28.6%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Supply chain disruptions, Intellectual property risks, Cybersecurity threats, Sales force challenges
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.63$, 5.89$]
- 2026-12-31 to 2027-12-31 estimated range: [1.19$, 4.18$]
Financial Metrics affecting the INDP estimates:
- Negative: with PPE of -0.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of 0 <= 2.40
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0
Short-term INDP quotes
Long-term INDP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $16.38MM | $15.37MM | $19.83MM |
| Operating Income | $-16.38MM | $-15.37MM | $-19.83MM |
| Non-Operating Income | $0.96MM | $0.34MM | $-1.02MM |
| R&D Expense | $7.62MM | $7.25MM | $9.34MM |
| Income(Loss) | $-15.42MM | $-15.02MM | $-20.85MM |
| Net Income(Loss)* | $-15.42MM | $-15.02MM | $-20.85MM |
| Stockholders Equity | $12.08MM | $3.94MM | $3.15MM |
| Assets | $14.92MM | $7.34MM | $9.31MM |
| Operating Cash Flow | $-13.41MM | $-12.32MM | $-14.82MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $17.14MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.00MM | $4.75MM | $17.54MM |
| Earnings Per Share** | $-51.41 | $-44.96 | $-21.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.